SAFETY DATA SHEETThis safety data sheet was created pursuant to the requirements of:Regula�on (EC) No. 1907/2006 as amended by Commission Regula�on(EU) 2020/878 and Regula�on (EC) No. 1272/2008
Issuing Date 27-Apr-2023

Revision Date 27-Apr-2023

Revision Number 1

SECTION 1: Iden�ﬁca�on of the substance/mixture and of the company/undertaking
1.1.

Product iden�ﬁer
Product Code(s)Product Name

Synonyms

40880008

IGH SHM Posi�ve Control DNA

None

40880010

IVS-0001 Clonal Control DNA

None

40880098

LymphoTrack B-Cell Low Posi�ve Control

None40880108

LymphoTrack T-Cell Low Posi�ve Control

None40880118

LymphoQuant B-Cell Internal Control

None40880128

LymphoQuant T-Cell Internal Control

None40880190

IVS-0004 Clonal Control DNA

None

40880370

IVS-0007 Clonal Control DNA

None

40880430

IVS-0008 Clonal Control DNA

None

40880490

IVS-0009 Clonal Control DNA

None

40880550

IVS-0010 Clonal Control DNA

None

40880730

IVS-0013 Clonal Control DNA

None

40881090

IVS-0019 Clonal Control DNA

None

40881210

IVS-0021 Clonal Control DNA

None

40881390

IVS-0024 Clonal Control DNA

None

40881690

IVS-0029 Clonal Control DNA

None

40881750

IVS-0030 Clonal Control DNA

None

40881810

IVS-0031 Clonal Control DNA

None

40920010

IVS-0000 Polyclonal Control DNA

None

Pure substance/mixture

Mixture1.2.

Relevant iden�ﬁed uses of the substance or mixture and uses advised against
Recommended use
Assay reagent
Uses advised against
For professional use only

1.3.

Details of the supplier of the safety data sheet
Importer
Invivoscribe Technologies
Zeppelinstrasse 185399 Hallbergmoos
Germany
Phone: +49 89 904 299 800

Supplier
Invivoscribe, Inc.
10222 Barnes Canyon Rd
Bldg. 1San Diego, CA 92121
Phone: +1 858-224-6600

Distributor
Invivoscribe Technologies, SARL
c/o Ficorec Domicilia�on Services
132, Boulevard Michelet
Hall Nord – 5ème étage
13008 Marseille
FRANCE
Tel: +33 (0)4 42 01 78 10

For further informa�on, please contact
E-mail address
customerservice@invivoscribe.com
1.4.

Emergency telephone number
Emergency telephone+49 89 904 299 800 (M-F 8:00 – 16:30 CET)Emergency telephone - §45 - (EC)1272/2008
Europe112

SDS – DNA Controls (CLP)-EN Rev. A | November 2023

1 / 9

Invivoscribe® DNA Controls

SECTION 2: Hazards iden�ﬁca�on
2.1.

Classiﬁca�on of the substance or mixture
Classiﬁcation according to Regulation (EC) No. 1272/2008 [CLP]This substance is classiﬁed as not hazardous according to regula�on (EC) 1272/2008 [CLP].

2.2. Label elements
Hazard statements
Not classiﬁed.
Unknown aqua�c toxicity
2.3.

Other hazards
No informa�on available.
Endocrine Disruptor
Informa�on

Contains 0 % of components with unknown hazards to the aqua�c environment.

This product does not contain any known or suspected endocrine disruptors.

SECTION 3: Composi�on/informa�on on ingredients
3.1

Substances
The product contains no substances which at their given concentra�on, are considered to be hazardous to health.
Full text of H- and EUH-phrases: see sec�on 16
Acute Toxicity Estimate
If LD50/LC50 data is not available or does not correspond to the classiﬁcation category, then the appropriate conversion value from
CLP Annex I, Table 3.1.2, is used to calculate the acute toxicity estimate (ATEmix) for classifying a mixture based on its components
This product does not contain candidate substances of very high concern at a concentra�on >=0.1% (Regula�on (EC) No. 1907/2006(REACH), Ar�cle 59)

SECTION 4: First aid measures
4.1.

Descrip�on of ﬁrst aid measures
Inhala�on
Eye contact
Skin contact
Inges�on

Remove to fresh air. Get medical aten�on if symptoms occur.
Rinse thoroughly with plenty of water for at least 15 minutes, li�ing lower and upper eyelids.
Consult a physician.
Wash skin with soap and water. Get medical aten�on if symptoms occur.
Do NOT induce vomi�ng. Never give anything by mouth to an unconscious person. Rinse mouth.
Get medical aten�on if symptoms occur.

4.2.

Most important symptoms and eﬀects, both acute and delayed
Symptoms
None known.
Eﬀects of Exposure
No informa�on available.

4.3.

Indica�on of any immediate medical aten�on and special treatment needed
Note to physicians
Treat symptoma�cally.

SECTION 5: Firefighting measures
5.1.

Ex�nguishing media
Suitable Ex�nguishing Media
Unsuitable ex�nguishing media

5.2.

Use ex�nguishing measures that are appropriate to local circumstances and the surrounding
environment.
No informa�on available.

Special hazards arising from the substance or mixture
Speciﬁc hazards arising from the No informa�on available.
chemicalSDS – DNA\RNA Controls (CLP)-EN Rev. A | November 2023

2 / 9

Invivoscribe® DNA Controls

SECTION 5: Firefighting measures
5.3.

Advice for ﬁreﬁghters
Special protec�ve equipment
and precau�ons for ﬁre-ﬁghters

Fireﬁghters should wear self-contained breathing apparatus and full ﬁreﬁgh�ng turnout gear. Use
personal protec�on equipment.

SECTION 6: Accidental release measures
6.1.

Personal precau�ons, protec�ve equipment and emergency procedures
Personal precau�ons
Ensure adequate ven�la�on.
For emergency responders
Use personal protec�on recommended in Sec�on 8.

6.2.

Environmental precau�ons
Environmental precau�ons

6.3.

Methods and material for containment and cleaning up
Methods for containment
Prevent further leakage or spillage if safe to do so.
Methods for cleaning up
Dam up. Soak up with inert absorbent material. Take up mechanically, placing in appropriate
containers for disposal.
Preven�on of secondary
Clean contaminated objects and areas thoroughly observing environmental regula�ons.
hazards

6.4.

Reference to other sec�ons
Reference to other sec�ons

See Sec�on 12 for addi�onal Ecological Informa�on.

See sec�on 8 for more informa�on See sec�on 13 for more informa�on

SECTION 7: Handling and storage
7.1.

Precau�ons for safe handling
Advice on safe
Handle in accordance with good industrial hygiene and safety prac�ce.
handling
General hygiene
Handle in accordance with good industrial hygiene and safety prac�ce.
considera�ons

7.2.

Condi�ons for safe storage, including any incompa�bili�esStorage Condi�ons
Keep containers �ghtly closed in a dry, cool and well-ven�lated place.
Storage class (TRGS
Storage class 10.
510)

7.3.

Speciﬁc end use(s)Speciﬁc use(s)The iden�ﬁed uses for this product are detailed in Sec�on 1.2.

SECTION 8: Exposure controls/personal protection
8.1.

Control parameters
Exposure Limits

This product, as supplied, does not contain any hazardous materials with occupa�onal exposure
limits established by the region speciﬁc regulatory bodies.

Biological occupa�onal exposure limits
This product, as supplied, does not contain any hazardous materials with biological limits established by the region speciﬁc regulatory
bodies.
Derived No Eﬀect Level (DNEL) - Workers
No informa�on available.
Derived No Eﬀect Level (DNEL) - General Public
No informa�on available.
Predicted No Eﬀect Concentra�on (PNEC)
No informa�on available.
8.2.

Exposure controls

SDS – DNA\RNA Controls (CLP)-EN Rev. A | November 2023

3 / 9

Invivoscribe® DNA Controls

SECTION 8: Exposure controls/personal protection
Engineering controls

Showers
Eyewash sta�ons
Ven�la�on systems.

Personal protec�ve equipment
Eye/face protec�on
Hand protec�on
Skin and body protec�on
Respiratory protec�onGeneral hygiene considera�ons
Environmental exposure
controls

Wear safety glasses with side shields (or goggles). Eye protec�on must conform to standard EN
166.
Wear suitable gloves. Gloves must conform to standard EN 374.
Wear suitable protec�ve clothing. (EN ISO 6529).
No protec�ve equipment is needed under normal use condi�ons. If exposure limits are exceededor irrita�on is experienced, ven�la�on and evacua�on may be required.
Handle in accordance with good industrial hygiene and safety prac�ce.
No informa�on available.

SECTION 9: Physical and chemical properties
9.1.

Informa�on on basic physical and chemical proper�es
Appearance
Physical state
LiquidColor
Colorless
Odor
Odorless
Odor thresholdNo informa�on available
PropertyMel�ng point / freezing point

ValuesIni�al boiling point and boilingrange
Flammability

Remarks • Method
No data available
No data available
No data available

Flammability Limit in Air
Upper ﬂammability or
explosive limits
Lower ﬂammability or
explosive limits
Flash point

No data available

Autoigni�on temperature

No data available

Decomposi�on temperature

No data available

pH

No data available

pH (as aqueous solu�on)

No data available
No data available

No data available

Kinema�c viscosity

No data available

Dynamic viscosity

No data available

Water solubility
Solubility(ies)

No data available
No data available

Par��on coeﬃcient

No data available

Vapor pressure

No data available

Rela�ve density

No data available

Bulk density

No data available

Liquid Density

No data available

Rela�ve vapor density

No data availablePar�cle characteris�cs

SDS – DNA\RNA Controls (CLP)-EN Rev. A | November 2023

4 / 9

Invivoscribe® DNA Controls

SECTION 9: Physical and chemical properties

9.2.

Par�cle Size

No data availablePar�cle Size Distribu�on

No data available

Other informa�on
9.2.1.
9.2.2.

Information with regard to physical hazard classes
Not applicable
Other safety characteristics
No informa�on available

SECTION 10: Stability and reactivity
10.1. Reac�vity
Reac�vity

None under normal use condi�ons.

10.2. Chemical stability
Stability
Explosion data

Stable under normal condi�ons.

Sensi�vity to mechanical impact

None.

Sensi�vity to sta�c discharge

None.

10.3. Possibility of hazardous reac�ons
Possibility of hazardous reac�ons

None under normal processing.

10.4. Condi�ons to avoid
Condi�ons to avoid

None known based on informa�on supplied.

10.5. Incompa�ble materials
Incompa�ble materials

None known based on informa�on supplied.

10.6. Hazardous decomposi�on products
Hazardous decomposi�on products

None known based on informa�on supplied.

SECTION 11: Toxicological information
11.1. Informa�on on hazard classes as deﬁned in Regula�on (EC) No 1272/2008
Informa�on on likely routes of exposure
Product Informa�on
Inhala�on
Eye contact

Speciﬁc test data for the substance or mixture is not available.

Skin contact

Speciﬁc test data for the substance or mixture is not available. Contact with eyes may cause
irrita�on.
Speciﬁc test data for the substance or mixture is not available.

Inges�on

Speciﬁc test data for the substance or mixture is not available.

Symptoms related to the physical, chemical and toxicological characteris�cs
Symptoms
None known.
Acute toxicity
Numerical measures of toxicity
Based on available data, the classiﬁca�on criteria are not met.
Component Informa�on
Delayed and immediate eﬀects as well as chronic eﬀects from short and long-term exposure
SDS – DNA\RNA Controls (CLP)-EN Rev. A | November 2023

5 / 9

Invivoscribe® DNA Controls

SECTION 11: Toxicological information
Skin corrosion/irrita�on
Serious eye damage/eye
irrita�on
Respiratory or skin sensi�za�onGerm cell mutagenicity
Carcinogenicity
Reproduc�ve toxicity
STOT - single exposure
STOT - repeated exposure
Aspira�on hazard

Based on available data, the classiﬁca�on criteria are not met.
Based on available data, the classiﬁca�on criteria are not met.
Based on available data, the classiﬁca�on criteria are not met.
Based on available data, the classiﬁca�on criteria are not met.
Based on available data, the classiﬁca�on criteria are not met.
Based on available data, the classiﬁca�on criteria are not met.
Based on available data, the classiﬁca�on criteria are not met.
Based on available data, the classiﬁca�on criteria are not met.
Based on available data, the classiﬁca�on criteria are not met.

11.2. Informa�on on other hazards
11.2.1.
Endocrine disrupting properties
Endocrine disrup�ng proper�es
11.2.2.
Other information
Other adverse eﬀects

This product does not contain any known or suspected endocrine disruptors.
No informa�on available.

SECTION 12: Ecological information
12.1. Toxicity
Ecotoxicity
Unknown aqua�c toxicity

Based on available data, the classiﬁca�on criteria are not met. Based on available data, theclassiﬁca�on criteria are not met.
Contains 0 % of components with unknown hazards to the aqua�c environment.

12.2. Persistence and degradability
Persistence and degradability

No informa�on available.

12.3. Bioaccumula�ve poten�al
Bioaccumula�on

No informa�on available.

12.4. Mobility in soil
Mobility in soil

No informa�on available.

12.5. Results of PBT and vPvB assessment
PBT and vPvB assessment
The product does not contain any substance(s) classiﬁed as PBT or vPvB.
12.6. Endocrine disrup�ng proper�es
Endocrine disrup�ng proper�esThis product does not contain any known or suspected endocrine disruptors.

12.7. Other adverse eﬀects
Other adverse eﬀects

No informa�on available.

SECTION 13: Disposal considerations
13.1. Waste treatment methods
Waste from residues/unused
products
Contaminated packaging
Waste codes / waste
designa�ons according to EWC /AVV

Dispose of in accordance with local regula�ons. Dispose of waste in accordance withenvironmental legisla�on.
Do not reuse empty containers.
According to the European Waste Catalog, Waste Codes are not product speciﬁc, but applica�on
speciﬁc. Waste codes should be assigned by the user based on the applica�on for which the
product was used.

SDS – DNA\RNA Controls (CLP)-EN Rev. A | November 2023

6 / 9

Invivoscribe® DNA Controls

SECTION 14: Transport information
IMDG
14.1
14.2
14.3
14.4
14.5
14.6

RID

ADR

IATA

Not regulated
UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precau�ons for Users
Special Provisions

Not regulated
Not regulated
Not regulated
Not applicableNot applicable

14.7

Mari�me transport in bulk according
to IMO instruments

No informa�on available

14.1
14.2
14.3
14.4
14.5
14.6

UN numberUN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precau�ons for Users
Special Provisions

14.1
14.2
14.3
14.4
14.5
14.6

UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precau�ons for Users
Special Provisions

14.1
14.2
14.3
14.4
14.5
14.6

UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precau�ons for Users
Special Provisions
Note:

None

Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicableNone
Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicableNone
Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicable
None
None

SECTION 15: Regulatory information
15.1. Safety, health and environmental regula�ons/legisla�on speciﬁc for the substance or mixtureNa�onal regula�ons
Germany
Water hazard class (WGK)
non-hazardous to water (nwg)
European Union
Take note of Direc�ve 98/24/EC on the protec�on of the health and safety of workers from the risks related to chemical agents at
work.

SDS – DNA\RNA Controls (CLP)-EN Rev. A | November 2023

7 / 9

Invivoscribe® DNA Controls

SECTION 15: Regulatory information
Authoriza�ons and/or restric�ons on use:
This product does not contain substances subject to authoriza�on (Regula�on (EC) No. 1907/2006 (REACH), Annex XIV) This productdoes not contain substances subject to restric�on (Regula�on (EC) No. 1907/2006 (REACH), Annex XVII)Persistent Organic Pollutants
Not applicable
Ozone-deple�ng substances (ODS) regula�on (EC) 1005/2009
Not applicable
Interna�onal Inventories
Contact supplier for inventory compliance status
15.2. Chemical safety assessment
Chemical Safety Report

No informa�on available

SECTION 16: Other information
Key or legend to abbrevia�ons and acronyms used in the safety data sheet
Legend
ATE: Acute Toxicity Es�mate
SVHC: Substances of Very High Concern for Authoriza�on:
PBT: Persistent, Bioaccumula�ve, and Toxic (PBT) Substances
vPvB: Very Persistent and very Bioaccumula�ve (vPvB) Substances
Legend Sec�on 8: Exposure controls/personal protec�on
TWA
TWA (�me-weighted average)
Ceiling
Maximum limit value
SCBA
Self-contained breathing apparatus
Classiﬁca�on procedure
Classiﬁca�on according to Regula�on (EC) No. 1272/2008 [CLP]
Acute oral toxicity
Acute dermal toxicity
Acute inhala�on toxicity - gas
Acute inhala�on toxicity - vapor
Acute inhala�on toxicity - dust/mist
Skin corrosion/irrita�on
Serious eye damage/eye irrita�on
Respiratory sensi�za�on
Skin sensi�za�on
Mutagenicity
Carcinogenicity
Reproduc�ve toxicity
STOT - single exposure
STOT - repeated exposure
Acute aqua�c toxicity
Chronic aqua�c toxicity
Aspira�on hazard

SDS – DNA\RNA Controls (CLP)-EN Rev. A | November 2023

STEL*

STEL (Short Term Exposure Limit)
Skin designa�on

Method Used
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
On basis of test data
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method
Calcula�on method

8 / 9

Invivoscribe® DNA Controls

SECTION 16: Other information
Ozone

Calcula�on method

Key literature references and sources for data used to compile the SDS
Agency for Toxic Substances and Disease Registry (ATSDR)
U.S. Environmental Protec�on Agency ChemView Database
European Food Safety Authority (EFSA)
European Chemicals Agency (ECHA) Commitee for Risk Assessment (ECHA_RAC)
European Chemicals Agency (ECHA) (ECHA_API)
EPA (Environmental Protec�on Agency)
Acute Exposure Guideline Level(s) (AEGL(s))
U.S. Environmental Protec�on Agency Federal Insec�cide, Fungicide, and Roden�cide Act
U.S. Environmental Protec�on Agency High Produc�on Volume Chemicals
Food Research Journal
Hazardous Substance Database
Interna�onal Uniform Chemical Informa�on Database (IUCLID)
Japan GHS Classiﬁca�onAustralia Na�onal Industrial Chemicals No�ﬁca�on and Assessment Scheme (NICNAS)
NIOSH (Na�onal Ins�tute for Occupa�onal Safety and Health)Na�onal Library of Medicine's ChemID Plus (NLM CIP)
Na�onal Library of Medicine’s PubMed database (NLM PUBMED)
United States of America Na�onal Toxicology Program (NTP)New Zealand's Chemical Classiﬁca�on and Informa�on Database (CCID)
Organiza�on for Economic Co-opera�on and Development Environment, Health, and Safety Publica�ons
Organiza�on for Economic Co-opera�on and Development High Produc�on Volume Chemicals Program
Organiza�on for Economic Co-opera�on and Development Screening Informa�on Data Set
World Health Organiza�on
Issuing Date

27-Apr-2023

Revision Date

27-Apr-2023

Revision Note

Ini�al Release.

This safety data sheet complies with the requirements of Commission Regula�on (EU) 2020/878 of 18 June 2020 amending Regula�on (EC)No. 1907/2006
Disclaimer
The informa�on provided in this Safety Data Sheet is correct to the best of our knowledge, informa�on and belief at the date of its
publica�on. The informa�on given is designed only as a guidance for safe handling, use, processing, storage, transporta�on, disposal andrelease and is not to be considered a warranty or quality speciﬁca�on. The informa�on relates only to the speciﬁc material designated andmay not be valid for such material used in combina�on with any other materials or in any process, unless speciﬁed in the text.
End of Safety Data SheetSDS – DNA\RNA Controls (CLP)-EN Rev. A | November 2023

9 / 9